Last reviewed · How we verify

NCT07182669

Blood Flow and Oxygenation in the Portal Vein in Subjects With Chronic Narrowing of the Blood Vessels to the Gut

Not yet recruiting Last updated 19 September 2025
What this trial tests

trial in Chronic Mesenteric Ischemia in 40 participants. Not yet recruiting.

Timeline
1 October 2025
Primary endpoint
1 October 2027
1 October 2028

Quick facts

Lead sponsorRigshospitalet, Denmark
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment40
Start date1 October 2025
Primary completion1 October 2027
Estimated completion1 October 2028
Sites1 location across Denmark

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Chronic Mesenteric Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study the investigators will, with an Magnetic Resonance Imaging (MRI) method, measure the oxygen content in the portal vein, which conduct the blood from the guts to the liver. Examinations will be performed on 20 subjects with meal related abdominal pain due to severe narrowing of the vessels conduction blood to the guts,compared to 20 subjects with similar narrowing of the abdominal vessels, but without meal related pain. The goal of the study is to test a non-invasive, radiation free method to diagnose patients with abdominal pain due to compromized blood supply (chronic mesenteric ischemia).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Mesenteric Ischemia

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07182669.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing